Adma Biologics (ADMA) Operating Margin (2012 - 2026)
Adma Biologics (ADMA) operating margin from Jun 30, 2012 to Mar 31, 2026. The current Adma Biologics (ADMA) operating margin is 50.90%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Adma Biologics (ADMA)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 37.52% | +15.14% |
| 2024 | 32.59% | +289.05% |
| 2023 | 8.38% | -132.79% |
| 2022 | -25.55% | -64.58% |
| 2021 | -72.12% | -53.09% |
| 2020 | -153.74% | +8.94% |
| 2019 | -141.12% | -60.23% |
| 2018 | -354.86% | +41.00% |
| 2017 | -251.66% | +52.77% |
| 2016 | -164.73% | -25.12% |
| 2015 | -220.00% | -19.80% |
| 2014 | -274.32% | -44.92% |
| 2013 | -498.01% | -29.48% |
| 2012 | -706.25% | +16.18% |
| 2011 | -607.89% | N/A |
Comparison Adma Biologics (ADMA) operating margin with competitors
Adma Biologics (ADMA) operating margin is 50.90%.